Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft Mouse Models of Human Pancreatic Cancer
Authors:
- Yukako ItoYIYukako Ito
- Shinji KobuchiSKShinji Kobuchi
- Amiri KawakitaAKAmiri Kawakita
- Kazuki TosakaKTKazuki Tosaka
- Yume MatsunagaYMYume Matsunaga
- Shoma YoshiokaSYShoma Yoshioka
- Shizuka JonanSJShizuka Jonan
- Kikuko AmagaseKAKikuko Amagase
- Katsunori HashimotoKHKatsunori Hashimoto
- Mitsuro KandaMKMitsuro Kanda
- Takuya SaitoTSTakuya Saito
- Hayao NakanishiHNHayao Nakanishi
Open Access
Abstract
Mobilization of CTCs after various types of therapy, such as radiation therapy, has been reported, but systematic study of CTCs after chemotherapy remained quite limited. In this study, we sequentially examined CTC numbers after single-dose and repetitive-dose chemotherapy, including FORFIRINOX (FFX) and Gemcitabine and nab-Paclitaxel (GnP) using two pancreatic cancer xenograft models. CTC was detected by the immunocytology-based microfluidic platform. We further examined the dynamic change in the histology of primary tumor tissues during chemotherapy. We confirmed a transient increase in CTCs 1–2 weeks after single-dose and repetitive-dose of FFX/GnP chemotherapy. Histological examination of the primary tumors revealed that the peak period of CTC at 1–2 weeks after chemotherapy corresponded to the maximal destructive phase consisting of cell cycle arrest, apoptosis of tumor cells, and blood vessel destruction without secondary reparative tissue reactions and regeneration of tumor cells. These findings indicate that mobilization of CTCs early after chemotherapy is mediated by the shedding of degenerated tumor cells into the disrupted blood vessels driven by the pure destructive histological changes in primary tumor tissues. These results suggest that sequential CTC monitoring during chemotherapy can be a useful liquid biopsy diagnostic tool to predict tumor chemosensitivity and resistance in preclinical and clinical settings.Keywords
Funding Information
- Ministry of Education, Science, Sports, Culture, and Technology, Japan (21K06679, 2科技第3-7号)
- Grant-in-Aid for a Priority Research Project from the Knowledge Hub Aichi, Japan (21K06679, 2科技第3-7号)
This publication has 27 references indexed in Scilit:
- Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse modelsBreast Cancer Research and Treatment, 2017
- Clinical impact of circulating tumor cells and therapy response in pancreatic cancerEuropean Journal of Surgical Oncology, 2017
- Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?Nature Reviews Clinical Oncology, 2016
- Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell CancerPLOS ONE, 2015
- Reduced Dissemination of Circulating Tumor Cells With No-Touch Isolation Surgical Technique in Patients With Pancreatic CancerJAMA Surgery, 2014
- Mobilization of Viable Tumor Cells Into the Circulation During Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Guidelines for the welfare and use of animals in cancer researchBritish Journal of Cancer, 2010
- Monitoring Serial Changes in Circulating Human Breast Cancer Cells in Murine Xenograft ModelsCancer Research, 2008
- ESTABLISHMENT AND CHARACTERIZATION OF PTHRP-PRODUCING HUMAN PANCREATIC-CANCER CELL-LINEInternational Journal of Oncology, 1994
- ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN PANCREATIC-CANCER CELL-LINE (SUIT-2) PRODUCING CARCINOEMBRYONIC ANTIGEN AND CARBOHYDRATE ANTIGEN-19-91987